tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

NKTR Stock Latest News

Nektar Therapeutics says no cash deposits, securities at Silicon Valley Bank
The FlyNektar Therapeutics says no cash deposits, securities at Silicon Valley Bank
12d ago
NKTR
SIVB
Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results
Press ReleasesNektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results
24d ago
NKTR
Nektar reports Q4 EPS (32c), consensus (45c)
The FlyNektar reports Q4 EPS (32c), consensus (45c)
24d ago
NKTR
Nektar price target lowered to $3 from $5 at SVB Securities
The FlyNektar price target lowered to $3 from $5 at SVB Securities
29d ago
NKTR
Nektar Plunges after Topline Data Misses Primary Endpoint
Market NewsNektar Plunges after Topline Data Misses Primary Endpoint
29d ago
NKTR
Nektar downgraded to Underperform from Hold at Jefferies
The FlyNektar downgraded to Underperform from Hold at Jefferies
29d ago
LLY
NKTR
Nektar down 31% afterhours after update on rezpegaldesleukin in lupus
The FlyNektar down 31% afterhours after update on rezpegaldesleukin in lupus
29d ago
NKTR
Nektar reports Phase 2 data on rezpegaldesleukin in lupus
The FlyNektar reports Phase 2 data on rezpegaldesleukin in lupus
29d ago
LLY
NKTR
Nektar announces presentations on NKTR-255 at ASH annual meeting
The FlyNektar announces presentations on NKTR-255 at ASH annual meeting
3M ago
NKTR
Nektar to host virtual analyst and investor meeting
The FlyNektar to host virtual analyst and investor meeting
3M ago
NKTR
Nektar to host virtual analyst and investor meeting
The FlyNektar to host virtual analyst and investor meeting
3M ago
NKTR
Nektar to host virtual analyst and investor meeting
The FlyNektar to host virtual analyst and investor meeting
3M ago
NKTR
Nektar management to meet virtually with Mizuho
The FlyNektar management to meet virtually with Mizuho
4M ago
NKTR
Guggenheim starts Medicenna Therapeutics with a Buy on MDNA11 potential
The FlyGuggenheim starts Medicenna Therapeutics with a Buy on MDNA11 potential
4M ago
MDNA
NKTR
Nektar management to meet virtually with Mizuho
The FlyNektar management to meet virtually with Mizuho
4M ago
NKTR
PureTech Health (NASDAQ:PRTC) Considering Merger with Nektar
Market NewsPureTech Health (NASDAQ:PRTC) Considering Merger with Nektar
6M ago
NKTR
PRTC
Nektar & Bristol Myers Halt Their Combination Therapy Trials
Market NewsNektar & Bristol Myers Halt Their Combination Therapy Trials
11M ago
BMY
NKTR
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.